Holowaty, Maksym N. H. http://orcid.org/0000-0003-4118-3723
Lees, Matthew J. http://orcid.org/0000-0003-1422-0154
Abou Sawan, Sidney
Paulussen, Kevin J. M.
Jäger, Ralf http://orcid.org/0000-0002-7345-9635
Purpura, Martin
Paluska, Scott A.
Burd, Nicholas A. http://orcid.org/0000-0001-5581-3154
Hodson, Nathan http://orcid.org/0000-0003-1330-4030
Moore, Daniel R.
Funding for this research was provided by:
Mitacs (IT15730)
Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-04251)
Article History
Received: 20 April 2022
Accepted: 24 November 2022
First Online: 6 December 2022
Declarations
:
: RJ and MP are inventors of US Patent No. 11026691B2 and pending patent applications for the use of dileucine and have not been involved in the data collection or analysis. All other authors report no conflict of interest.
: This research was conducted on human participants, from which written informed consent was obtained.